About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ACOR - Acorda Therapeutics| Previous Close | $0.90 | Open | $0.89 |
| Volume | 465.6K | Market Cap | 40.06M |
| Yield | Last Dividend |
| Acorda Third Quarter 2020 Update: Webcas... | 6:00 AM |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its third quarter... | |
| Acorda Therapeutics (NASDAQ:ACOR) Rating... | 10/25/20 |
| Zacks Investment Research lowered shares of Acorda Therapeutics (NASDAQ:ACOR) from a hold rating to a sell rating in a research note published on Wedn... | |
| Acorda Therapeutics (NASDAQ:ACOR) Cut to... | 10/24/20 |
| Zacks Investment Research lowered shares of Acorda Therapeutics (NASDAQ:ACOR) from a hold rating to a sell rating in a research report released on Wed... | |
| Acorda Therapeutics (NASDAQ:ACOR) Tradin... | 10/24/20 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR)???s share price fell 7% on Thursday . The company traded as low as $0.77 and last traded at $0.87. 5,770,156 s... | |
| Zacks Investment Research Lowers Acorda ... | 10/24/20 |
| Zacks Investment Research cut shares of Acorda Therapeutics (NASDAQ:ACOR) from a hold rating to a sell rating in a report released on Wednesday, Zacks... | |
| Wedbush Brokers Raise Earnings Estimates... | 10/23/20 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) ??? Stock analysts at Wedbush boosted their Q3 2020 EPS estimates for Acorda Therapeutics in a research note i... | |
| Acorda Therapeutics (NASDAQ:ACOR) Stock ... | 10/22/20 |
| Acorda Therapeutics (NASDAQ:ACOR) was downgraded by Zacks Investment Research from a ???hold??? rating to a ???sell??? rating in a research report iss... | |
| Acorda Therapeutics (NASDAQ:ACOR) Shares... | 10/22/20 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 7% on Thursday . The company traded as low as $0.77 and last traded at $0.87. 5,770,156 shares traded han... | |
| Acorda Therapeutics Target of Unusually ... | 10/22/20 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) was the recipient of unusually large options trading on Tuesday. Stock investors purchased 3,794 call options ... | |
| Q3 2020 Earnings Estimate for Acorda The... | 10/21/20 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) ??? Equities research analysts at Wedbush upped their Q3 2020 EPS estimates for Acorda Therapeutics in a resea... | |
| Acorda Therapeutics (NASDAQ:ACOR) Downgr... | 10/21/20 |
| Acorda Therapeutics (NASDAQ:ACOR) was downgraded by Zacks Investment Research from a ???hold??? rating to a ???sell??? rating in a research note issue... | |
| Zacks Investment Research Downgrades Aco... | 10/21/20 |
| Acorda Therapeutics (NASDAQ:ACOR) was downgraded by Zacks Investment Research from a ???hold??? rating to a ???sell??? rating in a research note issue... | |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) ... | 10/20/20 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) saw a large increase in short interest during the month of September. As of September 30th, there was short in... | |
| Reviewing PDL BioPharma (NASDAQ:PDLI) & ... | 10/20/20 |
| PDL BioPharma (NASDAQ:PDLI) and Acorda Therapeutics (NASDAQ:ACOR) are both small-cap medical companies, but which is the better business? We will cont... | |
| Pain Management- New Discoveries And Tre... | 10/01/20 |
| The research report on Pain Management Market provides a comprehensive analysis of the market status and development trend, including types, applicati... | |
| The Daily Biotech Pulse: Marinus Epileps... | 09/15/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) 10X Genomics Inc (NASDAQ: TXG ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Ave... | |
| The Daily Biotech Pulse: Sanofi, GSK Beg... | 09/03/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (N... | |
| The Daily Biotech Pulse: Altimmune Repor... | 08/25/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Abbott Laboratories (NYSE: ABT ) Cancer Genetics Inc (NASDAQ: CGIX ) (announced a dea... | |
| The Daily Biotech Pulse: Gilead's Filgot... | 08/19/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) Avenue Therapeutics Inc (NASDAQ: ATXI ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI )... | |
| Acorda Reports Second Quarter 2020 Finan... | 08/04/20 |
| Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the second quarter ended June 30, 202 | |
| The Week Ahead In Biotech: Novavax Coron... | 08/02/20 |
| Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flo... | |
| Acorda Second Quarter 2020 Update: Webca... | 07/28/20 |
| Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its second quarter 2020 update and financial resu | |
| The Daily Biotech Pulse: Moderna To Kick... | 07/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alt... | |
| Is the Options Market Predicting a Spike... | 06/09/20 |
| Investors need to pay close attention to Acorda Therapeutics (ACOR) stock based on the movements in the options market lately. | |
| Acorda (ACOR) Down 11.8% Since Last Earn... | 06/04/20 |
| Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Acorda (ACOR) Q1 Earnings Lag Estimates,... | 05/06/20 |
| Acorda's (ACOR) earnings and revenues fall shy of estimates in the first quarter of 2020. The company withdraws revenue view for its Parkinson's disea... | |
| Acorda Therapeutics (ACOR) Reports Q1 Lo... | 05/05/20 |
| Acorda (ACOR) delivered earnings and revenue surprises of -45.71% and -28.58%, respectively, for the quarter ended March 2020. Do the numbers hold clu... | |
| Acorda Reports First Quarter 2020 Financ... | 05/05/20 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the f... | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
| Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... | |
| Acorda First Quarter 2020 Update: Webcas... | 04/28/20 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter... | |
| Date | 2020-08-04 (AMC) | Est. (EPS/Rev.) | ($0.48)/ 27.5M |
| Actual (EPS/Rev.) | $-0.35/ $33.62 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| LavaPit | Steve Pitkin | 57.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
